Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy
- PMID: 32667669
- PMCID: PMC7364371
- DOI: 10.1001/jamainternmed.2020.3539
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy
Erratum in
-
Addition of Group Members Supplement.JAMA Intern Med. 2021 Jul 1;181(7):1021. doi: 10.1001/jamainternmed.2021.1229. JAMA Intern Med. 2021. PMID: 33843945 Free PMC article. No abstract available.
Abstract
Importance: Many patients with coronavirus disease 2019 (COVID-19) are critically ill and require care in the intensive care unit (ICU).
Objective: To evaluate the independent risk factors associated with mortality of patients with COVID-19 requiring treatment in ICUs in the Lombardy region of Italy.
Design, setting, and participants: This retrospective, observational cohort study included 3988 consecutive critically ill patients with laboratory-confirmed COVID-19 referred for ICU admission to the coordinating center (Fondazione IRCCS [Istituto di Ricovero e Cura a Carattere Scientifico] Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy) of the COVID-19 Lombardy ICU Network from February 20 to April 22, 2020. Infection with severe acute respiratory syndrome coronavirus 2 was confirmed by real-time reverse transcriptase-polymerase chain reaction assay of nasopharyngeal swabs. Follow-up was completed on May 30, 2020.
Exposures: Baseline characteristics, comorbidities, long-term medications, and ventilatory support at ICU admission.
Main outcomes and measures: Time to death in days from ICU admission to hospital discharge. The independent risk factors associated with mortality were evaluated with a multivariable Cox proportional hazards regression.
Results: Of the 3988 patients included in this cohort study, the median age was 63 (interquartile range [IQR] 56-69) years; 3188 (79.9%; 95% CI, 78.7%-81.1%) were men, and 1998 of 3300 (60.5%; 95% CI, 58.9%-62.2%) had at least 1 comorbidity. At ICU admission, 2929 patients (87.3%; 95% CI, 86.1%-88.4%) required invasive mechanical ventilation (IMV). The median follow-up was 44 (95% CI, 40-47; IQR, 11-69; range, 0-100) days; median time from symptoms onset to ICU admission was 10 (95% CI, 9-10; IQR, 6-14) days; median length of ICU stay was 12 (95% CI, 12-13; IQR, 6-21) days; and median length of IMV was 10 (95% CI, 10-11; IQR, 6-17) days. Cumulative observation time was 164 305 patient-days. Hospital and ICU mortality rates were 12 (95% CI, 11-12) and 27 (95% CI, 26-29) per 1000 patients-days, respectively. In the subgroup of the first 1715 patients, as of May 30, 2020, 865 (50.4%) had been discharged from the ICU, 836 (48.7%) had died in the ICU, and 14 (0.8%) were still in the ICU; overall, 915 patients (53.4%) died in the hospital. Independent risk factors associated with mortality included older age (hazard ratio [HR], 1.75; 95% CI, 1.60-1.92), male sex (HR, 1.57; 95% CI, 1.31-1.88), high fraction of inspired oxygen (Fio2) (HR, 1.14; 95% CI, 1.10-1.19), high positive end-expiratory pressure (HR, 1.04; 95% CI, 1.01-1.06) or low Pao2:Fio2 ratio (HR, 0.80; 95% CI, 0.74-0.87) on ICU admission, and history of chronic obstructive pulmonary disease (HR, 1.68; 95% CI, 1.28-2.19), hypercholesterolemia (HR, 1.25; 95% CI, 1.02-1.52), and type 2 diabetes (HR, 1.18; 95% CI, 1.01-1.39). No medication was independently associated with mortality (angiotensin-converting enzyme inhibitors HR, 1.17; 95% CI, 0.97-1.42; angiotensin receptor blockers HR, 1.05; 95% CI, 0.85-1.29).
Conclusions and relevance: In this retrospective cohort study of critically ill patients admitted to ICUs in Lombardy, Italy, with laboratory-confirmed COVID-19, most patients required IMV. The mortality rate and absolute mortality were high.
Conflict of interest statement
Figures
Similar articles
-
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394. JAMA. 2020. PMID: 32250385 Free PMC article.
-
Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.JAMA Netw Open. 2022 Oct 3;5(10):e2238871. doi: 10.1001/jamanetworkopen.2022.38871. JAMA Netw Open. 2022. PMID: 36301541 Free PMC article.
-
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy.Crit Care Resusc. 2020 Sep;22(3):200-211. doi: 10.1016/S1441-2772(23)00387-3. Crit Care Resusc. 2020. PMID: 32900326 Free PMC article.
-
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270. JAMA Netw Open. 2020. PMID: 32543702 Free PMC article. Review.
-
Critical illness-associated cerebral microbleeds: What we learned after the COVID-19 pandemic. A systematic review.J Clin Neurosci. 2023 Nov;117:91-97. doi: 10.1016/j.jocn.2023.09.028. Epub 2023 Sep 30. J Clin Neurosci. 2023. PMID: 37783069 Review.
Cited by
-
Estimating lengths-of-stay of hospitalised COVID-19 patients using a non-parametric model: a case study in Galicia (Spain).Epidemiol Infect. 2021 Apr 27;149:e102. doi: 10.1017/S0950268821000959. Epidemiol Infect. 2021. PMID: 33902779 Free PMC article.
-
Effectiveness of dexmedetomidine combined with high flow nasal oxygen and long periods of awake prone positioning in moderate or severe COVID-19 pneumonia.J Clin Anesth. 2021 Sep;72:110261. doi: 10.1016/j.jclinane.2021.110261. Epub 2021 Mar 31. J Clin Anesth. 2021. PMID: 33839432 Free PMC article. No abstract available.
-
Network meta-analysis of deaths from various underlying diseases after COVID-19 infection.Front Public Health. 2022 Aug 25;10:959073. doi: 10.3389/fpubh.2022.959073. eCollection 2022. Front Public Health. 2022. PMID: 36091527 Free PMC article.
-
Transcriptomic clustering of critically ill COVID-19 patients.Eur Respir J. 2023 Jan 27;61(1):2200592. doi: 10.1183/13993003.00592-2022. Print 2023 Jan. Eur Respir J. 2023. PMID: 36104291 Free PMC article.
-
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.Lancet. 2020 Oct 24;396(10259):1335-1344. doi: 10.1016/S0140-6736(20)32009-2. Epub 2020 Sep 25. Lancet. 2020. PMID: 32987007 Free PMC article.
References
-
- Covid-19 coronavirus pandemic. Updated July 3, 2020. Accessed April 12, 2020. https://www.worldometers.info/coronavirus
-
- Lombardia Notizie Online. Posted November 7, 2019. Accessed April 12, 2020. https://www.regione.lombardia.it/wps/portal/istituzionale/HP/lombardia-n...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous